Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Dale Jonathan Terasaki

TitleAffiliate - DHHA
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Caprio E, Belfer K, Terasaki D. Exploring the Role of Psychologists on Addiction Consult Services in Acute Care Settings. J Clin Psychol Med Settings. 2025 Apr 26. PMID: 40281325.
      View in: PubMed
    2. Terasaki D. A Critique of Phenobarbital Tapers With Buprenorphine or Methadone Initiations. J Addict Med. 2025 Apr 17. PMID: 40243173.
      View in: PubMed
    3. Calcaterra SL, Terasaki D. When Usual Care Is Subpar Care for Hospitalized Patients With Opioid Use Disorder. JAMA Intern Med. 2025 Apr 07. PMID: 40193083.
      View in: PubMed
    4. Steil L, Terasaki D, Reiss R, Deaney M. Review of acamprosate pharmacokinetics and dosing strategies. Ment Health Clin. 2025 Apr 01; 15(2):56-61. PMID: 40224514.
      View in: PubMed
    5. Terasaki D, Frank JW, Schacht J. Chronic Pain Associated Alcohol Use Disorder Among Participants in a Small Clinical Trial. J Addict Med. 2025 Mar-Apr 01; 19(2):236-237. PMID: 39446063.
      View in: PubMed
    6. Terasaki D, Loh R, Simpson S. Two Clinical Insights on Methamphetamine Withdrawal at a Safety-net Hospital. J Addict Med. 2025 Jan-Feb 01; 19(1):118. PMID: 39230516.
      View in: PubMed
    7. Terasaki D. Acute Subjective Experiences of Intravenous Ketamine Therapy Among Medically Hospitalized Patients with Alcohol Use Disorder. Psychedelic Med (New Rochelle). 2024 Jun; 2(2):116-126. PMID: 40051584.
      View in: PubMed
    8. Terasaki D, Abts D, Ferraro K. Questioning methadone split-dosing for analgesia among hospitalized patients with opioid use disorder. Addiction. 2024 Dec; 119(12):2044-2047. PMID: 38615677.
      View in: PubMed
    9. Terasaki D, Ellinwood A, White D. Quadruple pharmacotherapy for alcohol use disorder tolerable yet insufficient: a case report. Subst Abuse Treat Prev Policy. 2024 Feb 29; 19(1):18. PMID: 38424567.
      View in: PubMed
    10. Lyden J, Loh R, Braun H, Terasaki D. Characterizing safer drinking strategies among hospitalized adults with severe alcohol use disorder; a cross-sectional secondary analysis. J Addict Dis. 2024 Oct-Dec; 42(4):551-555. PMID: 37946362.
      View in: PubMed
    11. Terasaki D, Hanratty R, Thurstone C. More than MAT: lesser-known benefits of an inpatient addiction consult service. Hosp Pract (1995). 2023 08; 51(3):107-109. PMID: 37314327.
      View in: PubMed
    12. Deaney M, Terasaki D. Intramuscular, extended-release naltrexone inadvertently administered in the deltoid muscle: A case report. J Am Pharm Assoc (2003). 2023 Jul-Aug; 63(4):1245-1248. PMID: 37207707.
      View in: PubMed
    13. Terasaki D, Kulick B, Calcaterra S, Ray L. Phenobarbital for alcohol withdrawal in the context of the opioid epidemic: a neglected caveat. Addiction. 2023 07; 118(7):1198-1200. PMID: 36967706.
      View in: PubMed
    14. Terasaki D. Self-reported Past Experiences With Naltrexone and Attitudes Toward Daily Adherence Among High-utilization Patients With Alcohol Use Disorder. J Addict Med. 2023 May-Jun 01; 17(3):371-372. PMID: 37267196.
      View in: PubMed
    15. Terasaki D, Loh R, Cornell A, Taub J, Thurstone C. Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates. Addict Sci Clin Pract. 2022 11 22; 17(1):64. PMID: 36419181.
      View in: PubMed
    16. Terasaki D, Brady J. Severe, Nondelirium Agitation as an Underreported Characteristic of Precipitated Fentanyl Withdrawal: A Case Report. J Addict Med. 2023 Jan-Feb 01; 17(1):111-113. PMID: 35914120.
      View in: PubMed
    17. Terasaki D. Cardiovascular medications on discharge for patients with chest pain and concurrent cocaine use. Am J Emerg Med. 2022 08; 58:315-316. PMID: 35279327.
      View in: PubMed
    18. Mortaji P, Terasaki D, Moo-Young J. Advanced Inpatient Management of Opioid Use Disorder in a Patient Requiring Serial Surgeries. J Gen Intern Med. 2021 08; 36(8):2448-2451. PMID: 33782885.
      View in: PubMed
    19. Terasaki D, Klie K. Tramadol Withdrawal in the Setting of Buprenorphine Induction: A Case Report. J Addict Med. 2020 May/Jun; 14(3):264-266. PMID: 31574012.
      View in: PubMed
    20. Terasaki D, Smith C, Calcaterra SL. Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol. Pharmacotherapy. 2019 10; 39(10):1023-1029. PMID: 31348544.
      View in: PubMed
    21. Terasaki D, Ornelas I, Saelens B. Length of Residence and Vehicle Ownership in Relation to Physical Activity Among U.S. Immigrants. J Immigr Minor Health. 2017 04; 19(2):484-488. PMID: 26868494.
      View in: PubMed
    22. Terasaki DJ, Gelaye B, Berhane Y, Williams MA. Anger expression, violent behavior, and symptoms of depression among male college students in Ethiopia. BMC Public Health. 2009 Jan 12; 9:13. PMID: 19138431.
      View in: PubMed
    Terasaki's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (69) concept(s)
    _
    Co-Authors Expand Description
    See all (8) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)